Will ULBI's Q1 2025 EPS beat forecasts?

**Ultralife's Q1 2025 EPS is unlikely to beat forecasts.** Here's why:

1. **Current Estimates**: Analysts are estimating an EPS of $0.15 for Q1 2025.
2. **Previous Performance**: In Q1 2024, ULBI's EPS was $0.10, which was a significant increase from the previous year's $0.01. However, this does not necessarily indicate a trend of consistent growth.
3. **Recent Challenges**: Ultralife has experienced a decline in net income, with a fall to $0.2 million from $2.9 million, indicating a challenging financial period. This suggests that the company may be struggling to maintain profitability.
4. **Revenue Decline**: The Communications Systems segment saw a 55.1% revenue drop compared to the previous year, primarily due to timing of orders and supply chain disruptions. This decline is a red flag for potential EPS shortfalls, as revenue is a key driver of earnings.
5. **Market Conditions**: Without specific information on the market conditions and ULBI's operational performance in Q1 2025, it's challenging to make a definitive forecast. However, the overall tone of the earnings outlook and the recent earnings call suggest caution.

In conclusion, given the decline in net income, the revenue drop in the Communications Systems segment, and the challenging financial period Ultrulife is navigating, it's prudent to expect that the Q1 2025 EPS may not beat forecasts. Investors should monitor the company's strategic moves and operational improvements to gauge potential future growth.